Summary
Edwards Lifesciences Corporation (EW) has filed an 8-K report on April 24, 2018, primarily to disclose its financial results for the first quarter of 2018. The filing incorporates by reference a press release issued on the same date, which contains the detailed financial performance for the period. Investors should refer to this press release for specific figures related to revenue, earnings, and other key financial metrics, as the 8-K itself does not contain these details directly but serves as the official notification of their release.
Key Highlights
- 1Disclosure of First Quarter 2018 Financial Results: The primary purpose of this 8-K is to announce the company's financial performance for the first quarter ending March 31, 2018.
- 2Press Release as Primary Source of Information: The detailed financial results are provided in a press release, furnished as Exhibit 99.1, and incorporated by reference into the filing.
- 3Event Date is April 23, 2018: The underlying event, the release of financial results, occurred on April 23, 2018, with the filing made on April 24, 2018.
- 4Standard SEC Disclosure: This filing follows standard procedures for public companies to report significant events, such as quarterly earnings.
- 5No New Material Events Beyond Financial Results: The 8-K does not indicate any other significant business developments, mergers, acquisitions, or material changes in management beyond the financial reporting.
Frequently Asked Questions
The 8-K filing does not contain the specific financial results directly. These details are provided in the press release dated April 24, 2018, which is furnished as Exhibit 99.1 to this filing. Investors need to review Exhibit 99.1 for actual revenue, earnings per share (EPS), and other key financial figures.
This 8-K filing primarily reports historical financial results for the first quarter of 2018. Any forward-looking statements or guidance would be contained within the referenced press release (Exhibit 99.1), and investors should consult that document for such information.
The filing is specifically related to the company's financial results and condition for the first quarter of 2018. It does not appear to disclose any other significant changes to business operations, strategy, or management structure. Investors should refer to the press release for any additional commentary on business performance or outlook.